Journal profile · UROLOGY & NEPHROLOGY
NEPHRON
ISSN 1660-8151 · eISSN 2235-3186 · S. Karger AG · SWITZERLAND
NEPHRON: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.27; hybrid open access; median 139 days to acceptance (98 articles, last 24 months); acceptance rate 23.9% (journal website); 96 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
NEPHRON is published by S. Karger AG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renal Diseases and Glomerulopathies, Dialysis and Renal Disease Management and Chronic Kidney Disease and Diabetes, together about 32.1% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Nephron comprises sections “Clinical Practice”, "World Kidney Health" and “Experimental Nephrology and Genetics”, which are under the editorship of internationally recognized leaders and specialized associate editors. Apart from high-quality original research, Nephron publishes invited reviews/mini-reviews on up-to-date topics. The section “Clinical Practice” also includes Second Opinion articles, which provide a platform for international experts and opinion leaders to cast a critical eye over published papers dealing with hot topics in clinical and experimental nephrology. The section "World Kidney Health" covers issues from global kidney health and pathologies, patient centeredness and patient care, healthcare environment and public health policy. The section “Experimental Nephrology and Genetics” includes case studies of genetic interest articles that provide clinically relevant examples of the genetic heterogeneity of renal diseases.
From the journal's Aims & Scope
Research area (LetPub): UROLOGY & NEPHROLOGY
Editor-in-chief Ariela BenigniPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Renal Diseases and GlomerulopathiesMedicine12.5%
- Dialysis and Renal Disease ManagementMedicine12.4%
- Chronic Kidney Disease and DiabetesMedicine7.2%
- Acute Kidney Injury ResearchMedicine4.9%
- Parathyroid Disorders and TreatmentsMedicine4.6%
- Electrolyte and hormonal disordersMedicine4.4%
- Renal and Vascular PathologiesMedicine4.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.27LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- CiteScore (publisher)
- 4.9Publisher website ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 0.89LetPub ·
- h-index
- 68LetPub ·
- h-index
- 118OpenAlex ·
- i10-index
- 5,046OpenAlex ·
- 2-year mean citedness
- 1.86OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 16.67%LetPub ·
Volume
- Articles per year
- 82LetPub ·
Articles by year OpenAlex count · 10,363 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 18 | 7 |
| 2025 | 96 | 39 | 152 |
| 2024 | 76 | 30 | 255 |
| 2023 | 134 | 47 | 838 |
| 2022 | 93 | 54 | 847 |
| 2021 | 134 | 61 | 1,740 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
139 daysMedian, submission to acceptance · P25–P75 105 days – 223 days
- Acceptance to online
- median 28 days (98 articles)
- Submission to online
- median 189 days
- Sample
- 98 articles with submission and acceptance dates (183 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 23.9%Publisher website ·
- Submission to final decision
- 56 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteExcerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- SWITZERLAND
- Language
- English
- ISSN
- 1660-8151
- Electronic ISSN
- 2235-3186
- Latest issue on the website
- Volume 150, Issue 8 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about NEPHRON
What CAS zone is NEPHRON in?
In the 2025 upgraded edition of the CAS Journal Ranking, NEPHRON is in Zone 4 of Medicine, and in Zone 4 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of NEPHRON?
The latest impact factor listed by LetPub is 2.27; CiteScore 4.9, h-index 118.
How long does peer review take at NEPHRON?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 105–223 days); the journal's website gives an acceptance rate of 23.9%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index NEPHRON?
According to LetPub and DOAJ records, NEPHRON is indexed in SCIE and Scopus.
Is NEPHRON open access, and what is the APC?
NEPHRON is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .